Overview

Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis

Status:
Completed
Trial end date:
2020-02-06
Target enrollment:
Participant gender:
Summary
Study of the efficacy, safety, and tolerability of serlopitant for the treatment of pruritus in adults with prurigo nodularis
Phase:
Phase 3
Details
Lead Sponsor:
Menlo Therapeutics Inc.
Vyne Therapeutics Inc.
Treatments:
Serlopitant